You just read:

Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer

News provided by

Halozyme Therapeutics, Inc. , Eisai Inc.

Jul 31, 2015, 07:55 ET